Loading
Loading
Verified employee & interview reviews
Hyderabad, Telangana
Laurus Labs Limited is a prominent Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad, Telangana. Founded in 2005 by Dr. Satyanarayana Chava, the company has grown into a research-driven, integrated player with a global leadership position in select Active Pharmaceutical Ingredients (APIs) and a rapidly expanding footprint in finished dosages and contract services. The core operations of Laurus Labs are structurally divided into four major business segments: Generic APIs, Generic Finished Dosage Forms (FDF), Contract Development and Manufacturing Organization (CDMO) services, and Biotechnology. In its foundational Generic API vertical, the company stands as a global leader in the supply of anti-retroviral (ARV) APIs and intermediates, playing a critical role in providing affordable HIV/AIDS treatments worldwide. Additionally, its API portfolio includes advanced therapies for oncology, cardiovascular diseases, anti-diabetics, and gastrointestinal therapeutics, supported by one of India's largest high-potency API manufacturing capacities. In the Generic Formulations segment, Laurus Labs utilizes its backward-integration capabilities to develop and manufacture oral solid dosage forms, including tablets and capsules. Its state-of-the-art manufacturing facilities, primarily located hubs like Visakhapatnam, Hyderabad, and Bengaluru, maintain rigorous compliance with global regulatory standards, having received approvals from major agencies such as the USFDA, WHO, UK-MHRA, EMA, and Japan's PMDA. Adapting to evolving global outsourcing trends, the company's custom synthesis division, Laurus Synthesis, operates as a trusted CDMO partner. This segment provides end-to-end drug development, clinical phase supply, and commercial manufacturing services to global innovator pharmaceutical, crop science, animal health, and specialty chemical companies. Furthermore, Laurus Labs entered the biotechnology sector in 2020 through the strategic acquisition of Richcore Lifesciences, subsequently rebranded as Laurus Bio. This subsidiary leverages precision microbial fermentation and recombinant technology to produce animal-origin-free recombinant proteins, growth factors, and specialized enzymes catering to regenerative medicine, vaccines, cultured meat, and alternative food protein industries. Financially, Laurus Labs is publicly traded on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE) under the ticker LAURUSLABS. Driven by a large workforce that includes thousands of scientists and R&D personnel, the company places a heavy emphasis on smart and green chemistry technologies to optimize manufacturing efficiency. Through strategic joint ventures, such as its recent collaboration with Slovenia-based KRKA, and partnerships to democratize cutting-edge treatments like CAR-T cell therapy in India, Laurus Labs continues to advance its position across global healthcare, nutritional, and life science markets.
No reviews yet for Laurus Labs. Be the first to share your workplace experience on Rewyoo.